For the Inventor, By the Inventor

Enter assignee name

Seattle, WA, United States of America

Kineta, Inc.

USPTO Granted Patents = 14

CIPO Patents = 1

EPO Patents = 3

Trademarks = 8

Forward Citations = 17

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

Shawn P Iadonato (10 out of 28 patents)

Kristin M Bedard (10 out of 10 patents)

Kerry W Fowler (4 out of 45 patents)

4. Matthew Cullen (3 out of 10 patents)

5. Myra Wang Imanaka (3 out of 3 patents)

6. Benito Munoz (2 out of 55 patents)

7. Cecilia M Bastos (2 out of 32 patents)

8. Megan Foley (2 out of 8 patents)

9. Bradley Tait (2 out of 19 patents)

10. Bolin Geng (1 out of 10 patents)

11. Markus Haeberlein (1 out of 9 patents)

12. Dennis E Hruby (1 out of 52 patents)

13. Tove C Bolken (1 out of 24 patents)

14. Dongcheng Dai (1 out of 50 patents)

15. Sean M Amberg (1 out of 19 patents)

14 patents: Sort by Forward Citations

1. 12319698 - Proteasome activity enhancing compounds (2025-06-03),

2. 12180189 - Proteostasis regulators (2024-12-31),

3. 11958873 - Proteasome activity enhancing compounds (2024-04-16),

4. 9956285 - Anti-viral compounds (2018-05-01),

5. 9884876 - Anti-viral compounds, pharmaceutical compositions, and methods of use thereof (2018-02-06),

6. 9555106 - Anti-viral compounds (2017-01-31),

7. 9458492 - Methods and cells for identifying RIG-I pathway regulators (2016-10-04),

8. 9408826 - Isoflavone anti-viral compounds (2016-08-09),

9. 9301952 - Diarylpyridine anti-viral compounds (2016-04-05),

10. 9115065 - Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with Arenaviruses (2015-08-25),

11. 9073946 - Anti-viral compounds (2015-07-07),

12. 8927561 - Pyrimidinedione anti-viral compounds (2015-01-06),

13. 8895608 - Sulfonamide anti-viral compounds (2014-11-25),

14. 8871799 - Iminochromene anti-viral compounds (2014-10-28),

Kineta, Inc. is a biotechnology company focused on developing novel therapeutics for immune diseases and viral infections. The company's pipeline includes candidates for autoimmune diseases, chronic pain, and infectious diseases. Kineta's innovative approach to drug development includes a focus on small molecule drug discovery and immune modulation. With a diverse team of experienced scientists and industry leaders, Kineta is committed to advancing breakthrough treatments for patients in need.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

14 Patents

#124 in Seattle, WA

#455 in Washington

#21,640 in US

#40,937 in the World

Seattle, WA, United States of America

Kineta, Inc.

Forward Citations = 17

21 inventors:

Shawn P Iadonato (10 out of 28 patents)

Kristin M Bedard (10 out of 10 patents)

Kerry W Fowler (4 out of 45 patents)

4. Matthew Cullen (3 out of 10 patents)

5. Myra Wang Imanaka (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…